| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.32 | 2e-07 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.2 | 1e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.2 | 3e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 4e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |